tiprankstipranks
Advertisement

PTIN - ETF AI Analysis

Compare

Top Page

PTIN

Pacer Trendpilot International ETF (PTIN)

Rating:62Neutral
Price Target:
PTIN’s rating suggests it is a solid but not top-tier international ETF, with its quality driven largely by strong holdings in global leaders like ASML, HSBC, Novartis, and AstraZeneca, all of which show healthy financial performance and supportive earnings outlooks. These financially robust companies, especially in pharmaceuticals and banking, help support the fund’s overall appeal, while some concerns around high valuations, potential overbought conditions, and leverage in certain holdings introduce risk. The main risk factor is the ETF’s reliance on a relatively concentrated group of large international financial and healthcare names, which could make performance more sensitive to sector-specific downturns.
Positive Factors
Strong Year-to-Date Performance
The fund has delivered strong gains so far this year, suggesting its strategy has recently worked well for investors.
Global Diversification
Holdings spread across many countries, including Japan, the U.S., Europe, and Asia, help reduce the impact of problems in any single market.
Leading Global Companies in Top Holdings
The ETF’s largest positions include well-known international leaders in technology, finance, and health care that have generally shown solid performance this year.
Negative Factors
Relatively High Expense Ratio
The fund’s fees are on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.
Short-Term Performance Volatility
The recent one-month decline shows that the fund’s returns can be bumpy over shorter periods, which may unsettle more cautious investors.
Heavy Exposure to Financials and Broad 'General' Category
A large share of assets in financial stocks and a broad, less-specific 'General' bucket may increase sensitivity to sector downturns and make the fund’s risk profile harder to gauge.

PTIN vs. SPDR S&P 500 ETF (SPY)

PTIN Summary

The Pacer Trendpilot International ETF (PTIN) tracks the Pacer Trendpilot International Index and invests in large, well-established companies outside the U.S. It owns big names like Samsung Electronics and Nestlé, and spreads money across many countries such as Japan, the UK, and Canada, as well as sectors like financials, technology, and health care. PTIN uses a rules-based “trend” approach that can shift between stocks and cash, aiming to grow your money while trying to reduce big losses. A key risk is that it still follows global stock markets, so its value can go up and down, especially when international markets are volatile.
How much will it cost me?The Pacer Trendpilot International ETF (PTIN) has an expense ratio of 0.67%, which means you’ll pay $6.70 per year for every $1,000 invested. This is higher than average because it uses an active strategy to adjust between equities and cash based on market trends, aiming to balance growth and risk. Active management typically comes with higher costs compared to passive ETFs.
What would affect this ETF?PTIN's focus on developed international markets and large-cap stocks could benefit from global economic growth and technological advancements, especially with holdings like ASML and SAP in the tech sector. However, the ETF may face challenges from rising interest rates, which could impact financial sector performance, and geopolitical tensions or regulatory changes in key regions like Europe and Asia. Its dynamic Trendpilot strategy may help mitigate risks during market downturns.

PTIN Top 10 Holdings

PTIN is leaning heavily on international blue chips, with Samsung Electronics and SK hynix setting the tone as a rising-but-volatile semiconductor duo that can swing returns. ASML adds more chip exposure, keeping the fund tied to the global tech cycle. On the steadier side, HSBC, Royal Bank of Canada, and Mitsubishi UFJ give the ETF a solid financial backbone, generally rising and smoothing out bumps. Roche and Novartis offer stable health care ballast, while lagging names like AstraZeneca and Nestlé are losing a bit of steam. Overall, it’s a developed-markets ex-U.S. play anchored in semis, banks, and pharma.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Samsung Electronics3.77%$6.96M₩10.00T>230.73%
SK hynix Inc.2.69%$4.96M₩10.00T>507.36%
ASML Holding NV2.68%$4.95M€547.84B135.43%
76
Outperform
HSBC Holdings1.52%$2.81M£270.81B72.84%
80
Outperform
Roche Holding AG1.28%$2.37M$348.49B38.24%
73
Outperform
Royal Bank Of Canada1.22%$2.25M$290.61B62.00%
75
Outperform
Novartis AG1.20%$2.21MCHF231.75B31.63%
80
Outperform
Mitsubishi UFJ Financial Group1.11%$2.05M¥39.93T62.91%
76
Outperform
AstraZeneca1.10%$2.03M$263.99B3.27%
80
Outperform
Nestlé SA1.08%$1.99MCHF208.38B11.94%
71
Outperform

PTIN Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
36.46
Positive
100DMA
35.38
Positive
200DMA
33.79
Positive
Market Momentum
MACD
0.19
Negative
RSI
59.03
Neutral
STOCH
89.48
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PTIN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.37, equal to the 50-day MA of 36.46, and equal to the 200-day MA of 33.79, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 59.03 is Neutral, neither overbought nor oversold. The STOCH value of 89.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PTIN.

PTIN Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$184.84M0.67%
62
Neutral
$943.66M0.29%
67
Neutral
$846.22M0.52%
66
Neutral
$711.25M0.59%
63
Neutral
$253.93M0.62%
59
Neutral
$111.83M0.37%
63
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PTIN
Pacer Trendpilot International ETF
37.16
8.76
30.85%
IDHQ
Invesco S&P International Developed High Quality ETF
TILC
Thrivent International Large Cap ETF
FYLD
Cambria Foreign Shareholder Yield ETF
TPIF
Timothy Plan International ETF
TLCI
Touchstone International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement